News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Neeraj Agarwal: Poor Outcomes with SOC in mHSPC Prostate Cancer Patients With HRR Mutation
Jun 19, 2025, 16:21

Neeraj Agarwal: Poor Outcomes with SOC in mHSPC Prostate Cancer Patients With HRR Mutation

Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on X:

“Just in Clinical Cancer Research AACR 
Congrats Chadi Hage Chehade, Umang Swami and Huntsman GU team
Poor outcomes with SOC Rx in mHSPC prostate cancer with HRRm in 637 real-world US patients 
need to add PARPi”

MHSPC prostate cancer

Title: Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer

Authors: Chadi Hage Chehade, Ryon P. Graf, Zeynep Irem Ozay, Georges Gebrael, Nicolas Sayegh, Gerald Li, Benjamin L. Maughan, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami

Read Full Article.

Neeraj Agarwal: Poor Outcomes with SOC in mHSPC Prostate Cancer Patients With HRR Mutation

 More posts featuring Neeraj Agarwal on OncoDaily.

Benjamin L Maughan cancer Chadi Hage Chehade Emmanuel S Antonarakis Georges Gebrael Gerald Li Neeraj Agarwal Nicolas Sayegh OncoDaily Oncology prostate cancer Rana R. McKay Ryon P. Graf Umang Swami Zeynep Irem Ozay
Special Coverage
Positive
Jul 9, 2025, 13:08
Dana-Farber's New Cancer Hospital will Strengthen Boston’s Position as a Global Leader in Oncology
Opinion
Jul 9, 2025, 11:58
Geography is a Critical Cancer Risk Factor Shaped by Environment, Genetics, and Lifelong Exposures - Jarurat Care
Blog
Jul 9, 2025, 11:56
The SIOG 2025 Scientific Programme is Live
Blog
Jul 9, 2025, 11:26
Don't Miss Out the Upcoming 2nd National Cancer Summit - National Cancer Institute of Kenya
Blog
Jul 9, 2025, 11:10
Hamza Hashmi: ASCO 2025 Summary - Best of Myeloma-Key Trials and Clinical Insights
Blog
Jul 9, 2025, 11:03
How Are New Treatment Pathways Reshaping the Future of Gastric and Liver Cancer Care? - APGCS
Blog
Jul 9, 2025, 10:38
Guillermo Chantada Delivers Keynote on Childhood Cancer Strategy in Latin America
Blog
Jul 9, 2025, 10:27
Abdu Adem Yesufe: Make a positive impact in underserved areas in Ethiopia
Insight
Jul 9, 2025, 10:27
Akhil Kapoor: Critical Aspects of the SANO trial
Blog
Jul 9, 2025, 10:06
Galip Can Uyar: Can Metformin Improve Outcomes in Metastatic Hormone-sensitive Prostate Cancer?
Blog
Jul 9, 2025, 09:56
Letter from the Founder of Pan-African PGS Education and Research Initiative
Blog
Jul 9, 2025, 09:42
Zainab Shinkafi-Bagudu Announced Umaru Shinkafi Legacy Foundation Essay Competition 2025 Results